cGMP, enzyme-free human pluripotent stem cell selection and passaging reagent
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
To request a Letter of Authorization (LOA) for ReLeSR’s (Catalog #100-0484) Drug Master File, click here.
Figure 1. Passaging Protocol Comparison
ReLeSR™ passaging protocol eliminates difficult and time-consuming steps, thereby enabling easy culture scale-up.
Surface area of 4 x 6 well plates (230 cm²) is comparable to that of a T225 flask (225 cm²).
TeSR™ = TeSR™ family media (mTeSR™1, TeSR™2, or TeSR™-E8™).
Figure 2. Selectively Detach Undifferentiated Cells
ReLeSR™ selectively detaches undifferentiated cells from pluripotent stem cell cultures without manual selection. Optimally-sized aggregates are generated following shaking/tapping of the cultureware.
(A) An hPSC culture ready for passaging. Note the presence of differentiated cells at the edge of the undifferentiated hPSC colony. (B) Following incubation with ReLeSR™, the undifferentiated hPSC colony starts to lift off of the cultureware. The differentiated cells remain attached to the cultureware. (C) Following shaking/tapping of the cultureware, the undifferentiated cells completely lift off of the cultureware. (D) The undifferentiated hPSC colony is broken up into optimally-sized aggregates for replating.
Figure 3. Rescue Highly Differentiated Cultures
Poor quality human pluripotent stem cell cultures containing large proportions of differentiated cells can be rescued by passaging with ReLeSR™. (A) A poor quality hPSC culture containing ~50% undifferentiated cells. (B) Following passaging with ReLeSR™, the differentiated cells have largely been eliminated from the culture, with >90% undifferentiated cells present at the end of the next passage.
Figure 4. Select Putative iPS Cell Clones
Easily isolate newly generated human iPS cell colonies with ReLeSR™ by selectively detaching undifferentiated cells and leaving non reprogrammed cells behind.
(A) A TeSR™-E7™ reprogramming culture which has been treated with ReLeSR™ to detach the putative iPS cell colony, leaving the non-reprogrammed and differentiated cells behind. (B) Cultures contain a high proportion of undifferentiated cells by the end of the first passage.
Protocols and Documentation
Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.
This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.
Resources and Publications
Educational Materials (17)
Item added to your cart
PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED. FOR ADDITIONAL INFORMATION ON QUALITY AT STEMCELL, REFER TO WWW.STEMCELL.COM/COMPLIANCE.